Research
Prediction of outcome of non-small cell lung cancer patients treated with chemotherapy and bortezomib by time-course MALDI-TOF-MS serum peptide profiling
- † Equal contributors
Proteome Science 2009, 7:34 doi:10.1186/1477-5956-7-34
No comments have yet been made on this article.
